☆ 4.6 Article

Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology

CELLS (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Elevation of Cytoplasmic Calcium Suppresses Microtentacle Formation and Function in Breast Tumor Cells

Katarina T. Chang et al.

Summary: Calcium is a versatile signaling molecule that, when dysregulated, can increase cancer metastasis. However, its short-term effects are not well-studied. In this study, the researchers found that rapidly increasing cellular calcium levels can decrease the frequency and clustering of microtentacles, which are extensions that enhance cancer cell attachment. This suggests that modulating calcium levels may be a potential strategy to reduce metastasis in free-floating tumor cells.

CANCERS (2023)

Add to Collection

Article Oncology

Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical Impact

Vasileios Vardas et al.

Summary: This study investigated the expression of PD-L1, CTLA-4, GLU, and VIM in circulating tumor cells (CTCs) of triple negative breast cancer (TNBC) patients. All the examined proteins were upregulated in TNBC patients. GLU(+)VIM(+)CK(+) phenotype was more prevalent in metastatic TNBC, and significant correlation was found between PD-L1(+)CD45(-)CK(+) and CTLA-4(+)CD45(-)CK(+) phenotypes, suggesting the importance of dual inhibition in breast cancer. Moreover, GLU(+)VIM(+)CK(+) and PD-L1(+)CD45(-)CK(+) phenotypes were associated with shorter overall survival in TNBC patients, indicating their potential as prognostic biomarkers.

CANCERS (2023)

Add to Collection

Article Developmental Biology

Epithelial-to-mesenchymal transition of tumor cells: cancer progression and metastasis

Vasileios Vardas et al.

Summary: Detection and characterization of CTCs with an EMT phenotype in breast cancer patients was evaluated using the CellSearch system. Vimentin expression was studied and the presence of CK-VIM+CD45- phenotype was observed in both early and metastatic breast cancer patients, suggesting its potential importance in identifying undetectable tumor cells and providing additional information regarding metastasis.

INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2022)

Add to Collection

Article Health Care Sciences & Services

Detyrosinated α-Tubulin, Vimentin and PD-L1 in Circulating Tumor Cells (CTCs) Isolated from Non-Small Cell Lung Cancer (NSCLC) Patients

Spyridoula D. Katsarou et al.

Summary: This study evaluated the expression levels of cytoskeletal proteins in CTCs from NSCLC patients and found that high expression of GLU and VIM is associated with poor prognosis. PD-L1 is also related to patients' outcomes. Furthermore, the expression levels of TUB in CTCs inversely influence patients' overall survival.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Review Pharmacology & Pharmacy

Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options

Jae Young So et al.

Summary: This review discusses current therapies, studies in treatment resistance and relapse, including recent single-cell sequencing data, for triple-negative breast cancer (TNBC). It also examines changes in the transcriptome and epigenome of TNBC, mechanisms regulating the immune microenvironment, and provides new perspectives on patient stratification and treatment options.

PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Oncology

Microtubule disruption reduces metastasis more effectively than primary tumor growth

Keyata N. Thompson et al.

Summary: Clinical cancer imaging focuses on tumor growth, not metastasis. This study found that the microtubule-depolymerizing drug Vinorelbine can effectively reduce metastatic phenotypes of tumor cells and extend the survival of metastatic tumors, even with short-term treatment. Additionally, the study demonstrates the feasibility of using a small number of tumor cells from patient biopsies for drug response detection.

BREAST CANCER RESEARCH (2022)

Add to Collection

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Oncology

Liquid Biopsy: From Discovery to Clinical Application

Catherine Alix-Panabieres et al.

Summary: CTC and ctDNA have been recognized as promising biomarkers with various clinical applications, including early cancer detection and therapeutic monitoring. However, challenges such as standardization and validation of clinical effectiveness need to be addressed in this dynamic field of translational cancer research.

CANCER DISCOVERY (2021)

Add to Collection

Review Oncology

Clinical Relevance of Mesenchymal- and Stem-Associated Phenotypes in Circulating Tumor Cells Isolated from Lung Cancer Patients

Evangelia Pantazaka et al.

Summary: Lung cancer is the most common malignancy worldwide, characterized by late diagnosis and poor survival rates. Circulating tumor cells (CTCs) play a crucial role in lung cancer progression, acquiring EMT and CSC features to aid in survival and metastasis.

CANCERS (2021)

Add to Collection

Article Oncology

Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities

Laura M. Spring et al.

Summary: Patients with metastatic triple-negative breast cancer have a poor prognosis. Sacituzumab govitecan has shown promising therapeutic activity and received accelerated approval for the treatment of these patients. Limited information is available regarding adverse event management with this agent.

ONCOLOGIST (2021)

Add to Collection

Review Pharmacology & Pharmacy

Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer

K. G. K. Deepak et al.

PHARMACOLOGICAL RESEARCH (2020)

Add to Collection

Article Medical Laboratory Technology

Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer

William Jacot et al.

CLINICAL CHEMISTRY (2020)

Add to Collection

Article Biochemical Research Methods

Partial thermal imidization of polyelectrolyte multilayer cell tethering surfaces (TetherChip) enables efficient cell capture and microtentacle fixation for circulating tumor cell analysis

Julia A. Ju et al.

LAB ON A CHIP (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Systems Biology of Cancer Metastasis

Yasir Suhail et al.

CELL SYSTEMS (2019)

Add to Collection

Review Oncology

A framework for the development of effective anti-metastatic agents

Robin L. Anderson et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Add to Collection

Review Oncology

Breast Cancer, Version 4.2017 Clinical Practice Guidelines in Oncology

William J. Gradishar et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)

Add to Collection

Article Oncology

Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements

G. Kallergi et al.

BREAST CANCER RESEARCH (2018)

Add to Collection

Article Oncology

Phenotypic characterization of circulating tumor cells in triple negative breast cancer patients

Sofia Agelaki et al.

ONCOTARGET (2017)

Add to Collection

Meeting Abstract Oncology

Prospective Trial of Circulating Tumor Cells as a Biomarker for Early Detection of Recurrence in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiation Therapy

C. Chinniah et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)

Add to Collection

Review Multidisciplinary Sciences

Metastatic colonization by circulating tumour cells

Joan Massague et al.

NATURE (2016)

Add to Collection

Article Oncology

PD-L1 Expression Is Associated with Tumor FOXP3(+) Regulatory T-Cell Infiltration of Breast Cancer and Poor Prognosis of Patient

Zhenhua Li et al.

JOURNAL OF CANCER (2016)

Add to Collection

Article Oncology

Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells

Laure Cayrefourcq et al.

CANCER RESEARCH (2015)

Add to Collection

Article Oncology

High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer

Tao Qin et al.

ONCOTARGET (2015)

Add to Collection

Article Oncology

α-Tubulin Acetylation Elevated in Metastatic and Basal-like Breast Cancer Cells Promotes Microtentacle Formation, Adhesion, and Invasive Migration

Amanda E. Boggs et al.

CANCER RESEARCH (2015)

Add to Collection

Article Oncology

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

S. Muenst et al.

BREAST CANCER RESEARCH AND TREATMENT (2014)

Add to Collection

Article Oncology

Curcumin Targets Breast Cancer Stem-like Cells with Microtentacles That Persist in Mammospheres and Promote Reattachment

Monica S. Charpentier et al.

CANCER RESEARCH (2014)

Add to Collection

Review Oncology

Microtubules and their role in cellular stress in cancer

Amelia L. Parker et al.

FRONTIERS IN ONCOLOGY (2014)

Add to Collection

Article Oncology

Apoptotic Circulating Tumor Cells in Early and Metastatic Breast Cancer Patients

Galatea Kallergi et al.

MOLECULAR CANCER THERAPEUTICS (2013)

Add to Collection

Article Oncology

Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells

Jennifer R. Yoon et al.

BREAST CANCER RESEARCH AND TREATMENT (2011)

Add to Collection

Article Oncology

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients

Galatea Kallergi et al.

BREAST CANCER RESEARCH (2011)

Add to Collection

Article Oncology

Epithelial-to-Mesenchymal Transition Promotes Tubulin Detyrosination and Microtentacles that Enhance Endothelial Engagement

Rebecca A. Whipple et al.

CANCER RESEARCH (2010)

Add to Collection

Article Biochemistry & Molecular Biology

c-Src differentially regulates the functions of microtentacles and invadopodia

E. M. Balzer et al.

ONCOGENE (2010)

Add to Collection

Article Biochemistry & Molecular Biology

Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells

M. A. Matrone et al.

ONCOGENE (2010)

Add to Collection

Article Oncology

Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells

Rebecca A. Whipple et al.

CANCER RESEARCH (2008)

Add to Collection

Article Oncology

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

Galatea Kallergi et al.

BREAST CANCER RESEARCH (2008)

Add to Collection

Article Oncology

Detyrosinated microtubule protrusions in suspended mammary epithelial cells promote reattachment

Rebecca A. Whipple et al.

EXPERIMENTAL CELL RESEARCH (2007)

Add to Collection

Article Biochemistry & Molecular Biology

Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells

Galatea Kallergi et al.

MOLECULAR MEDICINE (2007)

Add to Collection

Article Cell Biology

Invadopodia and podosomes in tumor invasion

H Yamaguchi et al.

EUROPEAN JOURNAL OF CELL BIOLOGY (2006)

Add to Collection

Article Oncology

Circulating tumor cells in patients with breast cancer dormancy

SD Meng et al.

CLINICAL CANCER RESEARCH (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.